Ajay K. Nooka, MBBS, Clinical Pearls for Using Elranatamab in Relapsed or Refractory Multiple Myeloma

Posted: Thursday, September 21, 2023

Ajay K. Nooka, MBBS, of Winship Cancer Center of Emory University, discusses a pooled analysis of MagnetisMM studies, which showed that, in patients with relapsed or refractory multiple myeloma who have not yet been treated with B-cell maturation antigen-directed therapies, the bispecific antibody elranatamab was efficacious and well tolerated. Dr. Nooka reviewed practical clinical pearls on prescribing this medication.

---